Clinical Trials Browser

Phase EARLY_PHASE1 × Pancreatic Neoplasms × tremelimumab × Clear all

NCT04005690 2026-02-27

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms